The resilience of H. brevisubulatum’s I genome equips researchers with genetic tools to future-proof staple crops against climate extremes.

A new National Academies report recommends ways for the U.S. to reap the benefits of artificial intelligence in biotechnology ...

AgyemangFrom Monday, 17th March to Thursday 20th March, 2025, Ghana is hosting a gathering of science, health and ...

Vigil is the first cellular immunotherapy to demonstrate longer-term survival benefits in a randomized controlled trial of patients with solid tumors. The results of the company's Phase 2b study have ...

For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...

Saudi Arabia has made significant strides in the biotechnology sector following the launch of its national strategy in early 2024, aiming to position itself as a leading global hub in the field.The ...

INVINCIBLE-3 Study, and 25 patients have been screened Eight Swiss sites are activated in the INVINCIBLE-4 Study, and several ...

Anika Therapeutics (NASDAQ:ANIK – Free Report) had its target price reduced by Barrington Research from $25.00 to $20.00 in a research note released on Thursday,Benzinga reports. They currently have ...

StockNews.com started coverage on shares of Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) in a research report released on Thursday. The firm issued a buy rating on the biotechnology company’s ...

Sorghum is an increasingly important crop for animal and human nutrition, especially in arid and semi-arid regions, due to ...

The first phase of the MEER research was a joint effort of Shanghai Jiao Tong University, the Institute of Deep-sea Science ...

ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Regenxbio Inc. (RGNX) on Thursday reported a loss of $51.2 million in its fourth quarter. On a per-share basis, the Rockville, Maryland-based company said ...